- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Futura Medical Share News (FUM)
Share News for Futura Medical (FUM)
| Share Price: 71.50 | Bid: 70.00 | Ask: 73.00 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
Futura gets potential partners for premature-ejaculation drug
Tue, 9th Dec 2008 09:40
* Says early-stage study meets all main goals * Shares rise 5 pct
(Adds details)
In the study of 20 healthy volunteers, PET500 was shown to give a rapid and controlled reduction in penile sensitivity, thereby having the potential to prevent premature ejaculation, the company said in a statement. Shares of Futura Medical were up 1.25 pence at 27 pence at 0924 GMT on the London Stock Exchange.
(Reporting by Tresa Sherin Morera in Bangalore; Editing by Gopakumar Warrier) Keywords: FUTURAMEDICAL/
(tresa.sherin@thomsonreuters.com; +44 207 542 7717; Reuters Messaging: tresa.sherin@thomsonreuters.com)
COPYRIGHT
Copyright Thomson Reuters 2008. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Says early-stage study meets all main goals * Shares rise 5 pct
(Adds details)
Dec 9 (Reuters) - Futura Medical Plc said on Tuesday it received interest from a number of potential partners for its treatment for premature ejaculation as the drug showed positive results in an early stage study, sending Futura's shares up 5 percent. The pharmaceutical group said the Phase-I study of the drug, codenamed PET500 and being developed in gel and spray formulations, met all endpoints.
In the study of 20 healthy volunteers, PET500 was shown to give a rapid and controlled reduction in penile sensitivity, thereby having the potential to prevent premature ejaculation, the company said in a statement. Shares of Futura Medical were up 1.25 pence at 27 pence at 0924 GMT on the London Stock Exchange.
(Reporting by Tresa Sherin Morera in Bangalore; Editing by Gopakumar Warrier) Keywords: FUTURAMEDICAL/
(tresa.sherin@thomsonreuters.com; +44 207 542 7717; Reuters Messaging: tresa.sherin@thomsonreuters.com)
COPYRIGHT
Copyright Thomson Reuters 2008. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
BRIEF-Futura Medical says talks on re-licensing of csd500 progressing well
LONDON, Jan 7 (Reuters) - Futura Medical PLC: * Statement re share price movement * Confirms negotiations are progressing well for the[7 Jan '13]
BRIEF-Futura Medical raises 2.08 mln stg
LONDON, Sept 14 (Reuters) - Futura Medical PLC: * Placing to raise £2.08 million ((London Equities Newsroom; +44 20 7542 7717))[14 Sep '12]
BRIEF-Futura Medical notes CE mark for csd500 condom
LONDON, Aug 8 (Reuters) - Futura Medical PLC: * Award of the ce mark certificate to reckitt benckiser plc for csd500, the company's[8 Aug '11]
Futura's erection-boosting condom gets EU backing
LONDON, June 20 (Reuters) - British company Futura Medical said its erection-enhancing condom, licensed to Reckitt Benckiser for sale under its[20 Jun '11]
BRIEF-Futura Medical raises 3 mln stg via placing
LONDON, March 11 (Reuters) - Futura Medical PLC: * Placing to raise £3.20 million ((London Equities Newsroom; +44 20 7542 7717))[11 Mar '11]
BRIEF-Futura Medical signs marketing deal with Ansell
LONDON, Feb 7 (Reuters) - Futura Medical PLC: * Agreement with ansell for the commercialisation of pet500 * Will receive a significant[7 Feb '11]
BRIEF-Futura Medical sees short delay in condom CE mark
LONDON, Jan 18 (Reuters) - Futura Medical PLC: * Regulatory authority has minor points ahead of the award of the ce mark for csd500[18 Jan '11]
BRIEF-Futura Medical signs development agreement with GSK
LONDON, June 30 (Reuters) - Futura Medical PLC: * Signed a development agreement with glaxosmithkline (gsk) for development of tpr100[30 Jun '10]
